ARTUS MONO Artificial Urinary Sphincter
Feasibility of ARTUS MONO Artificial Urinary Sphincter Implant in Women
1 other identifier
interventional
3
2 countries
2
Brief Summary
The ARTUS MONO implant is an active implantable medical device (AIMD) that assist the urethral sphincter function of female patients suffering from moderate to severe urinary incontinence, by remotely opening and closing a cuff placed around the bladder neck. The purpose of this clinical investigation is to evaluate the feasibility of implantation of the device, its safety and its efficacy, when temporarily implanted in female patients scheduled for anterior pelvic exenteration for bladder cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2018
CompletedFirst Submitted
Initial submission to the registry
May 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2018
CompletedFirst Posted
Study publicly available on registry
October 12, 2018
CompletedOctober 19, 2018
October 1, 2018
4 months
May 25, 2018
October 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bladder catheterization in presence of ARTUS MONO cuff
Injection then re-aspiration of 50 cc of saline water through 18 Fr Foley catheter
Day 0
Secondary Outcomes (2)
ARTUS MONO cuff implant
Day 0
ARTUS MONO cuff activation
Day 0
Study Arms (1)
Active
EXPERIMENTALARTUS MONO
Interventions
Eligibility Criteria
You may qualify if:
- Female patients aged ≥ 18 yo
- BMI \> 18,5 and \< 35
- Patient scheduled for an anterior pelvic exenteration with ileal conduit urinary diversion
- Signed informed consent
You may not qualify if:
- Advanced bladder cancer with bladder neck and/or urethral extension
- Past pelvic radiation therapy
- Patient previously treated with an artificial urinary sphincter or other urogenital implant
- Positive urine culture during the past 2 weeks
- Indwelling bladder catheter during the past 2 weeks
- Documented history of sensitivity to silicone
- History of connectivitis disease
- Immunosuppressive therapy in the last 3 months
- Vulnerable subjects
- Participation in any other clinical investigation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Thomayer hospital
Prague, Czechia
Cochin Hospital
Paris, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolas BARRY DELONGCHAMPS, PR
Hôpital Cochin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2018
First Posted
October 12, 2018
Study Start
May 23, 2018
Primary Completion
September 26, 2018
Study Completion
September 26, 2018
Last Updated
October 19, 2018
Record last verified: 2018-10